[144] LifeStance Health Group, Inc. SEC Filing

Rhea-AI Filing Summary

LifeStance Health Group, Inc. (LFST) filed a Form 144 disclosing a proposed sale of 3,214,648 shares of Common Stock through Morgan Stanley & Co. LLC on 08/18/2025 on NASDAQ, with an aggregate market value of $17,391,245.68. The shares were originally acquired 06/10/2021 in a pre-IPO transaction from LifeStance Health Group Inc.; the filing reports total outstanding shares of 388,936,394. The filer certifies there is no undisclosed material adverse information and notes no securities were sold by the filer in the past three months.

Positive

• Planned sale disclosed with specific broker (Morgan Stanley & Co. LLC), date (08/18/2025), and aggregate value ($17,391,245.68)
• Acquisition details provided: shares were acquired 06/10/2021 in a pre-IPO transaction

Negative

• None.

Insights

Financial Analyst

TL;DR Large registered sale disclosed: 3.21M shares worth $17.39M planned via Morgan Stanley on 08/18/2025.

The filing is a routine Rule 144 notice indicating an insider or affiliate intends to sell previously acquired pre-IPO equity. It lists acquisition date (06/10/2021), original acquisition source (pre-IPO), and the broker handling the transaction. The notice affirms no undisclosed material adverse information and reports no sales in the prior three months. Without additional context on ownership percentage or lock-up constraints, this Form 144 itself is procedural; it documents intent to sell but does not confirm execution or market impact.

Corporate Governance Expert

TL;DR Disclosure complies with Rule 144; signer attests no undisclosed material information.

The submission provides required details: class of security, broker, share count, aggregate value, acquisition details, and certification language about material information and potential 10b5-1 plans. It notes the securities were purchased pre-IPO. The form contains no additional governance events, plan adoption dates, or signatures visible in the provided content. As presented, the filing meets disclosure mechanics but offers limited governance insight beyond the sale notice.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Morgan Stanley & Co. LLC 1585 Broadway New York NY 10036	3214648	17391245.68	388936394	08/18/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	06/10/2021	Pre-IPO Transactions	LifeStance Health Group Inc.			18446106	06/10/2021	Equity interests in the Issuer were purchased pre-IPO.

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the LFST Form 144 disclose?

It discloses a proposed sale of 3,214,648 shares of Common Stock valued at $17,391,245.68, to be sold via Morgan Stanley on 08/18/2025.

Who acquired the shares and when according to the filing?

The shares were acquired on 06/10/2021 in a pre-IPO transaction from LifeStance Health Group Inc.

Does the filing state whether any securities were sold in the past three months?

No; the Form 144 reports "Nothing to Report" for securities sold during the past three months.

Which broker is handling the proposed sale for LFST?

Morgan Stanley & Co. LLC, located at 1585 Broadway New York NY 10036, is listed as the broker.

How many shares outstanding does the filing list?

The filing lists 388,936,394 shares outstanding.